We have shown that this newly discovered molecule has an exceptional ability to inhibit hepatic steatosis by suppressing oxidative stress and inflammation and by acting on the SREBP1, PPARα, Nrf2, and NF-κB signaling pathways. The gene discussed is SREBF1; the disease is fatty liver disease.